Science

IMTECH takes up sample testing for Covid-19

Jyoti Singh New Delhi | Updated on April 03, 2020 Published on April 03, 2020

Covid-19 has posed several challenges to the healthcare sector. The limited number of test kits for Covid-19 is one such challenge. As of now, India has been primarily testing patients with a travel history. However, the rate of testing should improve in terms of testing per million population.

To boost its testing capacity, Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH) has stepped up to take up Covid-19 sample testing. This is in line with the directives issued by the Principal Scientific Adviser (PSA) to the Centre and the advisory issued by the Indian Council of Medical Research (ICMR) to operationalise Covid-19 testing by laboratories under CSIR and other labs affiliated to Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Atomic Energy (DAE).

“The initiative of ICMR to involve all government-accredited labs is a welcome step and will be a game changer in testing of Covid-19 samples. This would increase the testing rate among suspected patients. In the initial phase, IMTECH plans to operationalise capabilities to carry out testing of 50 to 100 samples a day, which can be subsequently ramped up as and when required,” said Dr Sanjeev Khosla, Director, IMTECH, Chandigarh.

The institution has augmented its capabilities to carry out clinical testing for COVID-19 and has the necessary expertise in molecular microbiology. The lab has the requisite infrastructure including Biosafety Level (BSL)-3 facility as the labs are advised to take all appropriate biosafety and bio-security precautions before testing. A newly constructed BSL-2+ virology lab equipped with Reverse Transcription Polymerase Chain Reaction (RT-PCR) equipment has also been established. All the mandatory approvals required for testing of clinical samples have been obtained to operationalise testing at the earliest.

Apart from testing of clinical samples, CSIR-IMTECH is also supporting healthcare professionals by providing Personal Protection Equipment (PPE) to prevent them from contracting any infection while serving patients. The institute is also extending help to the local administration and Red Cross Unit of Chandigarh by providing the logistical and infrastructure support. (India Science Wire)

 

@ashajyoti11

 

Published on April 03, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.